* ÇöÀç ÄÁÅÙÃ÷ Á¤º¸¸¦ Áغñ Áß¿¡ ÀÖ½À´Ï´Ù.
Purpose: Pulmonary large cell neuroendocrine carcinoma (LCNEC) is a high-grade lung neuroendo-crine tumor with a poor prognosis, similar to small cell lung cancer (SCLC). However, it remains un-clear ...
Introduction
Materials and Methods
Results
Discussion and Conclusion
Conflict of Interest
Acknowledgements
Supplementary Materials
References
¤ýClinical factors affecting the determination of radiotherapy-induced skin toxicity in breast cancer
¤ýAbscopal effect in the radio and immunotherapy
¤ýComputed tomography-based radiomic model predicts radiological response following stereotactic body radiation therapy in early-stage non-small-cell lung cancer and pulmonary oligo-metastases
¤ýHyperfractionated radiotherapy for re-irradiation of recurrent esophageal cancer
¤ýClinical features and treatment outcomes of resected large cell neuroendocrine carcinoma of the lung
¤ýGamma-ray irradiation modulates PGRMC1 expression and the number of CD56+ and FoxP3+ cells in the tumor microenvironment of endometrial endometrioid adenocarcinoma
¤ýPrognostic value of the maximum standardized uptake value for the locoregional control in early glottic cancer
¤ýRe-irradiation for recurrent or second primary head and neck cancer
¤ýEfficacy and safety of sequential neoadjuvant chemotherapy and short-course radiation therapy followed by delayed surgery in locally advanced rectal cancer: a single-arm phase II clinical trial with subgroup analysis between the older and young patients
¤ýImpact of somatic mutations on clinical and pathologic outcomes in borderline resectable and locally advanced pancreatic cancer treated with neoadjuvant chemotherapy and stereotactic body radiotherapy followed by surgical resection